Company Filing History:
Years Active: 2024
Title: **Innovations by Soo A Lim: Pioneering Biosignal Measurement Technology**
Introduction
Soo A Lim, an innovative inventor based in Seoul, South Korea, has made significant strides in the field of biosignal measurement technology. With a total of two patents to his name, Lim is at the forefront of developing devices that enhance the quality of healthcare monitoring. His work focuses on improving the methods of processing and transmitting electrocardiogram (ECG) data, which can greatly benefit both patients and medical professionals.
Latest Patents
Soo A Lim's latest patents include a **biosignal measuring device for converting and transmitting biosignals** and a **bio-signal data processing apparatus and method**. The first patent details a sophisticated biosignal measuring apparatus that features a sensing unit designed to capture a user's electrocardiogram data. It integrates a communication unit to establish a wireless connection with a data receiving device and employs a processing unit to manage real-time transmission characteristics based on the quality of communication. This innovative approach ensures that electrocardiogram data is accurately converted and transmitted efficiently.
The second patent outlines a bio-signal data processing apparatus equipped with a communicator for receiving electrocardiogram data. It includes a recording unit to log the data, a transmission delay determiner to assess and manage any delays in data transmission, and an output information generator that refines the electrocardiogram data for improved user interaction. These patents exemplify Lim’s commitment to advancing medical technology and enhancing patient diagnostics.
Career Highlights
Soo A Lim is currently affiliated with Atsens Co., Ltd., a company dedicated to pioneering advancements in the biomedical field. His contributions to the development of innovative medical devices reflect his expertise and dedication to improving healthcare outcomes through technology.
Collaborations
Lim collaborates with esteemed colleagues Jong Ook Jeong and Chang Ho Lee, who share a similar vision in advancing biosignal measurement technologies. Together, they are pushing the boundaries of what is possible in medical diagnostics and treatment, ensuring that their innovations will have a lasting impact in the healthcare sector.
Conclusion
Soo A Lim's inventive spirit and technical acumen are driving significant developments in the realm of biosignal measurement. With two patents already secured and a promising career at Atsens Co., Ltd., Lim's work is a testament to the potential of innovation in improving healthcare delivery. As he continues to collaborate with other talented individuals in the field, the future of biosignal technology looks bright.